RecruitingNCT06625346

Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

Clinical Outcomes in Newly Diagnosed Hypertensive Patients With EXTOR (Fixed-Dose Combination of Amlodipine/Valsartan) in Routine Pakistani Practice.


Sponsor

The Searle Company Limited Pakistan

Enrollment

420 participants

Start Date

Sep 28, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The American College of Cardiology/American Heart Association hypertension guidelines recommend treatment initiation with dual antihypertensive therapy in adults with stage 2 hypertension (corresponding to grade 1 and 2 in the ESH classification) and an average BP \>20/10 mm Hg above target. Amlodipine and valsartan are two of the most commonly prescribed medications for the treatment of hypertension (high blood pressure). In Pakistan multiple studies were conducted on Hypertension and use of Single Pill Combination in uncontrolled Hypertension. However, no study was conducted to assess the role of Single Pill Combination (SPC) like Amlodipine and Valsartan in newly diagnosed hypertension and to assess their quality of life by patients' satisfaction with their medication after managing the hypertension with the SPC.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates how well a combination blood pressure medication called EXTOR (amlodipine and valsartan) works in people who have just been diagnosed with high blood pressure and have never been treated for it before. Researchers in Pakistan are tracking how patients respond over time. **You may be eligible if...** - You are between 18 and 70 years old - You have been newly diagnosed with high blood pressure (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg) - You have never taken blood pressure medication before **You may NOT be eligible if...** - You are already on blood pressure medication or have secondary hypertension - You are pregnant or breastfeeding - You have an acute illness or psychiatric condition - You have a known allergy to the EXTOR medication or its ingredients Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFixed-Dose Combination of Amlodipine/Valsartan

Amlodipine and valsartan are two of the most commonly prescribed medications for the treatment of hypertension (high blood pressure). Amlodipine is a calcium channel blocker that works by relaxing the blood vessels, while valsartan is an angiotensin receptor blocker that works by blocking the effects of the hormone angiotensin II, which causes blood vessels to constrict. The combination of amlodipine and valsartan in a single pill has been shown to be more effective in lowering blood pressure than either medication alone. This is because the two medications have different mechanisms of action and work together to provide a more comprehensive approach to blood pressure control.


Locations(2)

Kuwait Teaching Hospital

Peshawar, KPK, Pakistan

National Medical Centre

Karachi, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06625346


Related Trials